+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID04342546

Study of the NovaGray RILA Breast Test to Predict Radiotherapy Side Effects After Mastectomy With Immediate Implant Reconstruction

Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2026-04-13

250

Participants Needed

9

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the NovaGray RILA Breast4 tests ability to predict side effects linked to radiotherapy and the impact of immediate implant breast reconstruction in patients with breast cancer. The study focuses on women undergoing mastectomy followed by radiotherapy, which can cause side effects affecting cosmetic outcomes and quality of life. The test measures lymphocyte T-CD8 apoptosis to assess individual risk of severe radiation-induced breast fibrosis, potentially enabling personalized treatment planning. The study involves performing the NovaGray RILA Breast4 test using blood samples taken between 30 days before and the first day of radiotherapy, and again 12 months after radiotherapy ends. For patients receiving chemotherapy, the test is also done before the first chemotherapy injection, whether neoadjuvant or adjuvant. The intervention is a device-based test aimed at predicting radiosensitivity related to breast reconstruction and radiotherapy. Participants will have blood drawn for the test at specified times before and after treatments. Researchers will assess the tests ability to predict capsular contracture 12 months after radiotherapy, along with other outcomes such as cosmetic and functional results, patient satisfaction, and quality of life over a 24-month period. Follow-up includes monitoring surgical success, biological and tumor factors, and test stability after chemotherapy to understand the tests precision and clinical utility.

CONDITIONS

Brief Title

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction

Research Team

A

Aurore MOUSSION

E

Emmanuelle TEXIER

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here